CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2

Reviews in the Neurosciences

Volumn 21, Issue 1, 2010, Pages 19-28

  Schneider Gold, Christiane ^a   Timchenko, Lubov T ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CCUG repeats; Rate of protein synthesis; TOP mRNAs; Translational apparatus; ZNF9

Indexed keywords

UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 9; CNBP PROTEIN, HUMAN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; DOWN REGULATION; GENE MUTATION; HUMAN; INTRON; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY 2; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA METABOLISM; TERMINAL OLIGOPYRIMIDINE TRACT; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY; TANDEM REPEAT;

ANIMALS; HUMANS; MYOTONIC DYSTROPHY; PROTEIN BIOSYNTHESIS; RNA-BINDING PROTEINS; TANDEM REPEAT SEQUENCES;

EID: 77953175881     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2010.21.1.19     Document Type: Review

References (60)

1. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, Clen C, Alleman J, Wormskamp NG, Vooijs, Buxton J, Johnson K, Smeets HJM, Lennon GG, Carrano AV, Korneluk RG, Wieringa B, de Jong PJ. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992; 355:548-551.
2. Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Miller C, Gehrmann J, Housman D, Mendelsohn ME, Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest 1999; R1-7. (Pubitemid 29094060)
3. Botta A, Caldarola S, Vallo L, Bonifazi E, Fruci D, Gullotta F, Massa R, Novelli G, Loreni F. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy II (DM2). Biochem Biophys Acta 2006;1762:329-334.
4. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion J-P, Hudson T, Sohn R, Zemelman B, Snell-RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
5. Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, Aslanidis C, de Jong P, Jansen G, Anvret M, Riley B, Williamson R, Johnson K. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355:547-548.
6. Caskey CT, Swanson MS, Timchenko LT. Myotonic dystrophy: discussion of molecular mechanism. Cold Spring Harbor Symposia on Quantitative Biology "Function and dysfunction in the nervous system" 1996;61:607-614.
7. Charlet-B N, Savcur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002;10:45-53. (Pubitemid 34879148)
8. Chen W,Wang Y, Abe Y, Cheney L, Udd B, Li YP. Haploinsufficiency for Znf9 in Znf9+/-mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J Mol Biol 2007; 368:8-17. (Pubitemid 46441224)
9. Dansithong W, Wolf CM, Sarkar P, Paul S, Chiang A, Holt I, Morris GE, Branco D, Sherwood MC, Comai L, Berul CI, Reddy S. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. PLoS One 2008;3:1-18.
10. Dhaenens CM, Schraenmaschke S, Tran H, Vingtdeux V, Ghanem D, Leroy O, Delplanque J, Vanbrussel E, Delacourte A, Vermersch P, Maurage CA, Gruffat H, Sergeant A, Mahaadevan MS, Ishiura S, Bulée L, Cooper TA, Caillet-Boudin ML, Charlet-Berguerand B, Sablonnière B Sergeant N. Overexpression of MBLN Fetal isoforms and modified splicing of tau in DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol 2008; 210:467-478.
11. Ebralidze A, Wang Y, Petkova V, Ebralidze K, Junghans RP. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 2004; 303:383-387. (Pubitemid 38095780)
12. Flink IL, Morkin E. Alternatively processed isoforms of cellular nucleic acid-binding protein interact with a suppressor region of the human beta-myosin heavy chain gene. J Biol Chem 1995;270:6959-6965.
13. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-8.
14. Gerbasi VR, Link AJ. The myotonic dystrophy 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Mol Cell Proteomics 2007; 6:1049-1058.
15. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, Harper PS, Housman DE, Shaw DJ. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-6.
16. Harper PS. Myotonic Dystrophy. WB Saunders, London UK, 2001.
17. Huichalaf C, Schoser B, Schneider-Gold C, Jin B, Sarkar P, Timchenko L. Reduction of the rate of protein translation in patients with myotonic dystrophy 2. J Neurosci 2009;29:9042-9049.
18. Iadevaia V, Caldarola S, Tino E, Amaldi F, Loreni F. All translation elongation factors and e, f and h subunits of translation initiation factor 3 are encoded by 5′-terminal oligopyrimidine (TOP) mRNAs. RNA 2008;14:1730-1736.
19. Ishikawa K, Fujigasaki H, Saegusa H, Ohwada K, Fujita T, Iwamoto H, Komatsuzaki Y, Toru S, Toriyama H, Watanabe M, Ohkoshi N, Shoji S, Kanazawa I, Tanabe T, Mizusawa H. Abundant expression and cytoplasmic aggregations of □1A voltage dependent calcium channel protein associated with neurodegeneration in spino-cerebellar ataxia type 6. Hum Mol Genet 1999;8: 1185-1189.
20. Jansen G, Groenen PJ, Bächner D, Jap PH, Coerwinkel M, Oerlemans F, van den Broek W, Gohlsch B, Pette D, Plomp JJ, Molenaar PC, Nederhoff MG, van Echteid CJ, Dekker M, Berns A, Hameister H, Wieringa B. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 1996;13: 316-324.
21. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson. MS. A muscleblind knockout model for myotonic dystrophy. Science 2003;302:1978-1980.
22. Kassubek J, Juengling FD, Hofmann S, Rosenbohm A, Kurt A, Jurkatt-Rott K Steinbach P, Wolf M, Ludolph AC, Lehmann-Horn F, Lerche H, Weber YG. Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 2003; 348;73-76.
23. Kuyumcu-Martinez NM, Wang G-S, Cooper TA. Increased steady-state levels of CUGBP1 in myotonic dystrophy are due to PKC-mediated hyperphosphorylation. Mol Cell 2007;28:68-78.
24. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006; 15: 2087-2097.
25. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293:864-867.
26. Mahadevan MS, Yadava RS, Yu Q, Balijepalli S, Frenzel-McCardell CD, Bourne TD, Phillips LH. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet 2006; 38:1066-1070.
27. Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000; 289:1769-1772.
28. Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LPW. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 2006; 15:1808-1815.
29. Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N. Similar tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 2005;65:1636-1638. (Pubitemid 41689481)
30. Meola G, Sansome V. Cerebral involvement in myotonic dystrophies. Muscle Nerve 2007;36:294-306.
31. Meyuhas O. Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 2000;267:6321-6330.
32. Michelotti EF, Tomonaga T, Krutzsch H, Levens D. Cellular nucleic acid binding protein regulates the CT element of the human c-myc proto-oncogene. J Biol Chem 1995;270:9494-9.
33. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J 2000;19:4439-4448.
34. Minnerop M, Luders E, Specht K, Ruhlmann J, Schneider-Gold C, Schröder R, Thompson PM, Toga AW, Klockgether T, Kornblum C. Grey and white matter loss along midline structures in myotonic dystrophy type 2. J Neurol 2008;255: 1904-1909.
35. Munoz E, Rey MJ, Mila M, Cardozo A, Ribalta T, Tolosa E, Ferrer I. Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease. J Neurol Sci 2002;200:19. (Pubitemid 34792737)
36. Pellizzoni L, Cardinali B, Lin-Marq N, Mercanti D, Pierandrei-Amaldi P. A Xenopus laevis homologue of the La autoantigen binds the pyrimidine tract of the 5′ UTR of ribosomal protein mRNAs in vitro: implication of a protein factor in complex formation. J Mol Biol 1996;259:904-915. (Pubitemid 26229857)
37. Pellizzoni L, Lotti F, Maras B, Pierandrei-Amaldi P. Cellular nucleic acid binding protein binds a conserved region of the 5′ UTR of Xenopus laevis ribosomal protein mRNAs. J Mol Biol 1997; 267:264-275. (Pubitemid 27149839)
38. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing of regulated by CUG binding protein in myotonic dystrophy. Science, 1998;280:737-741.
39. Rajavashisth TB, Taylor AK, Andalibi A, Svenson KL, Lusis AJ. Identification of a zinc finger protein that binds to the sterol regulatory element. Science 1989;245:640-643. (Pubitemid 19213341)
40. Reddy S, Smith DB, Rich MM, Leferovich JM, Reilly P, Davis BM, Tran K, Rayburn H, Branson R, Cros D, Balice-Gordon RJ, Housman D. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 1996;13:325-335.
41. Roberts R, Timchenko NA, Miller JW, Reddy S, Caskey CT, Swanson MS, Timchenko LT. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci (USA) 1997;94:13221-13226.
42. Salisbury E, Sakai K, Schoser B, Huichalaf C, Schnider-Gold C, Nguen H, Wang G-L, Albrech JH, Timchenko LT. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. Exp Cell Res 2008;314:2266-2278.
43. Salisbury E, Schoser B, Schneider-Gold C, Wang G-L, Huichalaf C, Jin B, Sirito M, Sarkar P, Krahe R, Timchenko NA, Timchenko LT. Expression of RNA CCUG Repeats Dysregulates Translation and Degradation of Proteins in Myotonic Dystrophy 2 Patients. Am J Pathol 2009;175:748-762.
44. Sansone V, Meola G, Perani D, Fazio F, Garibotto V, Cotelli M, Cotelli M, Vitelli E. Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry 2006;77:425-426. (Pubitemid 43295181)
45. Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001;29:40-47.
46. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics and pathogenesis. Lancet Neurology 2004;3:291-304. (Pubitemid 38510200)
47. Sergeant N, Sablonniere B, Schraen-Maschke S, Ghestem A, Maurage CA, Wattez A, Vermersch P, Delacourte A. dysregulation of human brain microtubule associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet 2001;10:2143-2155. (Pubitemid 32998826)
48. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros E, Brisson E, Fouquet C, Butler-Browne G, Delacourte A, Junien C, Gourdon G. Mice transgenic for the human myotonic dystrophy with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 2001;10:2717-26.
49. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinucleotide repeat transcripts in nuclei of Myotonic Dystrophy cells and tissues. J Cell Biol 1995;128:995-1002.
50. Timchenko L, Monckton DG, Caskey CT. Myotonic dystrophy: an unstable CTG repeat in a protein kinase gene. Semin Cell Biol 1995;6:13-19.
51. Timchenko LT. Myotonic dystrophy: the role of RNA CUG repeats. Am J Hum Genet 1999; 64:360-364.
52. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Identification of a (CUG)n triplet repeat binding protein and its expression in myotonic dystrophy. Nucl Acids Res 1996; 24: 4407-4414. (Pubitemid 26388627)
53. Timchenko LT, Salisbury E, Wang GL, Nguyen H, Albrecht JH, Hershey JW, Timchenko NA. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver. J Biol Chem 2006;281:32806-32819.
54. Timchenko LT, Timchenko NA, Caskey CT, Roberts R. Novel proteins with binding specificity to DNA CTG and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 1996;5:115-121. (Pubitemid 26018282)
55. Timchenko NA, Cai Z-J, Welm AL, Reddy S, Ashizawa T, Timchenko LT. RNA CUG repeats sequester and alter protein levels and activity of CUGBP1. J Biol Chem 2001;276:7820-7826. (Pubitemid 37385575)
56. Timchenko NA, Iakova P, Cai Z-J, Smith JR, Timchenko LT. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 2001; 21:6927-6938.
57. Timchenko NA, Patel R, Iakova P, Cai Z-J, Quan L, Timchenko LT. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 2004;279:13129-39.
58. Vielhaber S, Jakubiczka S, Gaul C, Schoenfeld MA, Debska-Vielhaber G, Zierz S, Heinze HJ, Niessen HG, Kaufmann J. Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1. Muscle Nerve 2006;34:145-52.
59. Warden CH, Krisans SK, Purcell-Huynh D, Leete LM, Daluiski A, Diep A, Taylor BA, Lusis AJ. Mouse cellular nucleic acid binding proteins: a highly conserved family identified by genetic mapping and sequencing. Genomics 1994;24:14-9.
60. Zhang L, Lee JE, Wilusz J, Wilusz CJ. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells. J Biol Chem 2008;283: 22457-63.